BRIEF published on 11/05/2025 at 23:05, 29 days 6 hours ago Stabilis Solutions Reports Strong Q3 2025 Financial Results Financial Results Revenue Growth Market Demand LNG Expansion Galveston Project
PRESS RELEASE published on 11/05/2025 at 23:00, 29 days 6 hours ago Stabilis Solutions Announces Third Quarter 2025 Results Stabilis Solutions, Inc. reports Q3 2025 financial results with revenues up to $20.3 million and net income of $1.1 million. Focus on LNG solutions expansion and operational growth Financial Results Revenue Growth Stabilis Solutions LNG Solutions Q3 2025
BRIEF published on 10/23/2025 at 14:35, 1 month 12 days ago Stabilis Solutions Schedules Third Quarter 2025 Results Call Financial Results Conference Call Stabilis Solutions Clean Fueling Third Quarter 2025
PRESS RELEASE published on 10/23/2025 at 14:30, 1 month 12 days ago Stabilis Solutions Announces Third Quarter 2025 Conference Call and Webcast Date Stabilis Solutions, Inc. to announce Q3 2025 results on November 5, 2025, with a conference call on November 6, 2025. Find webcast details and contact information Conference Call Investor Relations Stabilis Solutions Clean Fueling Q3 2025 Results
BRIEF published on 10/09/2025 at 14:05, 1 month 26 days ago Stabilis Solutions Secures Long-Term LNG Bunkering Agreement at Gulf Coast Stabilis Solutions Marine Operations LNG Bunkering Gulf Coast Expansion Galveston LNG Facility
PRESS RELEASE published on 10/09/2025 at 14:00, 1 month 26 days ago Stabilis Solutions Announces Award of Long-Term Marine Bunkering Agreement To Anchor Its Gulf Coast Expansion Stabilis Solutions announces a 10-year marine bunkering agreement for LNG supply at Port of Galveston. Galveston LNG facility expansion to enhance liquefaction capacity Stabilis Solutions Marine Bunkering LNG Supply Port Of Galveston Liquefaction Facility
BRIEF published on 08/06/2025 at 23:35, 3 months 29 days ago Stabilis Solutions Reports Second Quarter 2025 Financial Results Financial Results Market Growth Stabilis Solutions LNG Solutions Q2 2025
PRESS RELEASE published on 08/06/2025 at 23:30, 3 months 29 days ago Stabilis Solutions Announces Second Quarter 2025 Results Stabilis Solutions, Inc. reports Q2 2025 financial results with $17.3M revenue, $0.6M net loss, and $1.5M Adjusted EBITDA. Company focuses on LNG solutions for high-performance brands Financial Results Stabilis Solutions LNG Solutions Q2 2025 High-performance Brands
BRIEF published on 07/30/2025 at 14:05, 4 months 5 days ago Stabilis Solutions Schedules Q2 2025 Financial Results Call Conference Call Financial Disclosure Stabilis Solutions Q2 2025 Results Webcast Access
PRESS RELEASE published on 07/30/2025 at 14:00, 4 months 5 days ago Stabilis Solutions Announces Second Quarter 2025 Conference Call and Webcast Date Stabilis Solutions, Inc. to issue Q2 2025 results on August 6, 2025, with a conference call on August 7, 2025, to discuss financial results and recent events Financial Results Conference Call Investor Relations Stabilis Solutions Q2 2025 Results
Published on 12/05/2025 at 02:35, 2 hours 48 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 23 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 18 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 23 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 32 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 12 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 23 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 22 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
